FOXO3 programs tumor-associated DCs to become tolerogenic in human and murine prostate cancer.

Watkins SK, Zhu Z, Riboldi E, Shafer-Weaver KA, Stagliano KE, Sklavos MM, Ambs S, Yagita H, Hurwitz AA

DOI: 10.1172/jci44325
Published: 2011 Apr
Container: The Journal of clinical investigation
Publisher: Not recorded
Open access: yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
serious concernRetraction Watch retraction: 1 retraction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1172/jci44325,
  title = {FOXO3 programs tumor-associated DCs to become tolerogenic in human and murine prostate cancer.},
  author = {Watkins SK and Zhu Z and Riboldi E and Shafer-Weaver KA and Stagliano KE and Sklavos MM and Ambs S and Yagita H and Hurwitz AA},
  year = {2011},
  journal = {The Journal of clinical investigation},
  doi = {10.1172/jci44325},
  url = {https://doi.org/10.1172/jci44325}
}

RIS

TY  - JOUR
TI  - FOXO3 programs tumor-associated DCs to become tolerogenic in human and murine prostate cancer.
AU  - Watkins SK
AU  - Zhu Z
AU  - Riboldi E
AU  - Shafer-Weaver KA
AU  - Stagliano KE
AU  - Sklavos MM
AU  - Ambs S
AU  - Yagita H
AU  - Hurwitz AA
PY  - 2011
JO  - The Journal of clinical investigation
DO  - 10.1172/jci44325
UR  - https://doi.org/10.1172/jci44325
ER  -

APA

SK, W., Z, Z., E, R., KA, S., KE, S., MM, S., S, A., H, Y., & AA, H. (2011). FOXO3 programs tumor-associated DCs to become tolerogenic in human and murine prostate cancer.. The Journal of clinical investigation. https://doi.org/10.1172/jci44325

Source records

pubmed · retrieved 2026-09-25T15:31:02.709Z